Efficacy and Safety Study of BIBW 2992 to Treat Lung Cancer Patients (TIMELY)
This study is currently recruiting participants.
Verified April 2013 by University College, London
Sponsor:
University College, London
Collaborator:
Boehringer Ingelheim Pharmaceuticals
Information provided by (Responsible Party):
University College, London
ClinicalTrials.gov Identifier:
NCT01415011
First received: August 10, 2011
Last updated: April 3, 2013
Last verified: April 2013
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study is currently recruiting participants. |
|---|---|
| Estimated Study Completion Date: | December 2015 |
| Estimated Primary Completion Date: | December 2014 (Final data collection date for primary outcome measure) |